Recent research focusing on Semaglutide at a dosage of 40mg is shedding new light on its potential effects. Preliminary findings suggest that this higher dosage may enhance the drug's ability to manage blood glucose, potentially offering more significant outcomes for individuals with insulin resistance. Further research is underway to fully underst